IRIS UniCatt

Petrillo, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.103
EU - Europa 2.476
AS - Asia 2.280
SA - Sud America 392
Continente sconosciuto - Info sul continente non disponibili 130
AF - Africa 67
OC - Oceania 8
AN - Antartide 1
Totale 8.457
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.030
SG - Singapore 1.149
DE - Germania 978
CN - Cina 512
SE - Svezia 351
BR - Brasile 312
FR - Francia 224
IT - Italia 223
VN - Vietnam 192
UA - Ucraina 160
GB - Regno Unito 124
IE - Irlanda 102
PL - Polonia 90
IN - India 87
RU - Federazione Russa 66
ID - Indonesia 65
FI - Finlandia 54
TR - Turchia 47
CA - Canada 37
HK - Hong Kong 34
JP - Giappone 31
BD - Bangladesh 29
AR - Argentina 25
IQ - Iraq 21
BE - Belgio 20
MX - Messico 18
CI - Costa d'Avorio 15
ZA - Sudafrica 15
ES - Italia 13
NL - Olanda 13
EC - Ecuador 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
MA - Marocco 10
PK - Pakistan 10
CL - Cile 9
IR - Iran 9
PH - Filippine 9
KE - Kenya 8
PE - Perù 8
VE - Venezuela 8
CH - Svizzera 7
CO - Colombia 7
PY - Paraguay 7
JO - Giordania 6
KR - Corea 6
KZ - Kazakistan 6
TN - Tunisia 6
AT - Austria 5
EG - Egitto 5
AU - Australia 4
HU - Ungheria 4
JM - Giamaica 4
LT - Lituania 4
LV - Lettonia 4
NO - Norvegia 4
TJ - Tagikistan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
MY - Malesia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PS - Palestinian Territory 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GE - Georgia 2
IS - Islanda 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
MM - Myanmar 2
NG - Nigeria 2
PT - Portogallo 2
TH - Thailandia 2
A1 - Anonimo 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 8.316
Salva come PNG Salva come JPEG
Città #
Singapore 689
Chandler 568
San Jose 349
Ashburn 272
Jacksonville 117
Beijing 112
Dublin 102
San Mateo 100
Warsaw 79
New York 78
Los Angeles 76
Nürnberg 74
Nanjing 73
Wilmington 73
Ann Arbor 66
Jakarta 62
Lauterbourg 53
Dearborn 52
Hanoi 50
Marseille 49
Boston 48
Ho Chi Minh City 47
Houston 40
Frankfurt am Main 39
Cattolica 35
Izmir 35
Munich 32
Hong Kong 30
Moscow 30
Rome 30
Dallas 29
Lawrence 29
São Paulo 29
Tokyo 29
Buffalo 28
Princeton 27
Seattle 25
Chicago 23
Paris 23
Santa Clara 21
Brussels 20
Hangzhou 20
Redwood City 20
Hefei 17
Kunming 17
Boardman 16
Lancaster 16
Milan 16
Abidjan 15
Fairfield 15
Helsinki 15
Mountain View 15
Shanghai 15
Changsha 14
Nanchang 14
Norwalk 14
Tianjin 13
Woodbridge 13
Bremen 12
Da Nang 12
Haiphong 12
Hebei 12
Leawood 12
London 12
Shenyang 12
Tashkent 12
University Park 12
Atlanta 11
Brooklyn 11
Council Bluffs 11
Detroit 10
Nuremberg 10
Phoenix 10
Denver 9
Dhaka 9
Düsseldorf 9
Falls Church 9
Guangzhou 9
Belo Horizonte 8
Brasília 8
Chennai 8
Hyderabad 8
Jinan 8
Johannesburg 8
Lima 8
Montreal 8
Orem 8
Redmond 8
San Francisco 8
Toronto 8
Baghdad 7
Bucchianico 7
Jiaxing 7
Manchester 7
Amsterdam 6
Can Tho 6
Curitiba 6
Edinburgh 6
Nairobi 6
Pasig 6
Totale 4.384
Salva come PNG Salva come JPEG
Nome #
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 311
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 240
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 236
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 233
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 216
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 194
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 191
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 185
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 184
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 184
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 181
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 180
Incidence and predictive factors for complications after uterine leiomyoma embolization 173
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 168
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 162
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 157
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 157
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 157
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 156
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 156
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 154
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6 150
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 149
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer 149
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 145
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 142
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 141
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 138
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 137
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 136
Targeting the hallmarks of ovarian cancer: The big picture 134
Laparoscopic En Bloc Right Diaphragmatic Peritonectomy for Diaphragmatic Endometriosis According to the Sugarbaker Technique 134
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 132
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 131
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 131
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 126
Restructuring surgical training after COVID-19 pandemic: A nationwide survey on the Italian scenario on behalf of the Italian polyspecialistic young surgeons society (SPIGC) 125
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: a multicenter, retrospective, observational pilot study in Italy 124
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 123
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 116
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 116
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 111
Incidence, predictors and clinical outcome of pancreatic fistula in patients receiving splenectomy for advanced or recurrent ovarian cancer: a large multicentric experience 110
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery 109
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 108
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies 108
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 106
Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study 103
Secondary cytoreduction in ovarian cancer: who really benefits? 100
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 99
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 98
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 95
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 95
The safety of bevazicumab for the treatment of ovarian cancer 93
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study 91
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study 83
Cytoreductive surgery plus platinum-based hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: A promising integrated approach to improve locoregional control 82
RE: Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery 77
Simple hysterectomy versus radical hysterectomy in early-stage cervical cancer: A systematic review and meta-analysis 52
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers 44
Sentinel node mapping, sentinel node mapping plus back-up lymphadenectomy, and lymphadenectomy in Early-sTage cERvical caNcer scheduled for fertilItY-sparing approach: The ETERNITY project 25
Natural language processing as consultation service platform or clinical decision support system in gynecologic oncology: a systematic review 14
Totale 8.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022566 0 25 11 43 35 25 10 98 40 57 92 130
2022/20231.263 154 203 118 225 53 171 66 75 141 11 28 18
2023/2024500 28 142 8 22 11 73 41 13 9 30 59 64
2024/20251.006 25 26 85 45 105 43 21 36 177 81 190 172
2025/20262.782 398 69 104 260 597 153 515 139 228 198 68 53
2026/2027121 89 32 0 0 0 0 0 0 0 0 0 0
Totale 8.457